Here, we test if TERT promoter mutations and TERT expression are associated with OS and progression free survival (PFS) under ICI, as well as clinicopathological and demographic parameters in multiple highly annotated melanoma cohorts with exome- and transcriptome sequencing. This evidence concerns the gene TERT and melanoma.